Enliven Therapeutics Inc (ELVN)

Mar 01, 2026

ELVN SEC FilingsEnliven Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 01, 2026

Feb 28, 2026

ELVN Should I Buy - Intellectia AI

Feb 28, 2026

Feb 27, 2026

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Exploring a 37.94% Upside Potential in Biotech - DirectorsTalk Interviews

Feb 27, 2026

Feb 25, 2026

Biotech fireside chat: Enliven Therapeutics at TD Cowen event - Stock Titan

Feb 25, 2026

Feb 25, 2026

Insider Trends: Can Enliven Therapeutics Inc disrupt its industryJuly 2025 Recap & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 25, 2026

Feb 24, 2026

ELVN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 24, 2026

(ELVN) Risk Channels and Responsive Allocation - Stock Traders Daily

Feb 24, 2026

Feb 21, 2026

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Feb 21, 2026

Feb 20, 2026

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Gem with 58% Upside and Strong Buy Ratings - DirectorsTalk Interviews

Feb 20, 2026

Feb 19, 2026

Enliven Therapeutics (NASDAQ:ELVN) Director Sells $32,201.40 in Stock - MarketBeat

Feb 19, 2026

Feb 19, 2026

Heyman, Enliven Therapeutics director, sells $32k in stock By Investing.com - Investing.com Canada

Feb 19, 2026

Feb 19, 2026

Plan-based 1,230-share sale by Enliven (ELVN) director disclosed - Stock Titan

Feb 19, 2026

Feb 19, 2026

Investment Report: Is SAIL forming a double bottomInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn

Feb 19, 2026

Feb 19, 2026

Market Catalysts: Is Enliven Therapeutics Inc a speculative investment2025 Institutional Moves & Verified Entry Point Detection - baoquankhu1.vn

Feb 19, 2026

Feb 18, 2026

Gains Report: Is First Internet Bancorp showing insider buyingJuly 2025 Action & High Conviction Investment Ideas - baoquankhu1.vn

Feb 18, 2026

Feb 18, 2026

Stock Market Recap: How sensitive is Enliven Therapeutics Inc to inflationJuly 2025 Rallies & Safe Capital Investment Plans - baoquankhu1.vn

Feb 18, 2026

Feb 17, 2026

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Short Interest Down 14.1% in January - MarketBeat

Feb 17, 2026

Feb 17, 2026

Can Enliven Therapeutics Inc disrupt its industryQuarterly Portfolio Summary & Breakout Confirmation Alerts - baoquankhu1.vn

Feb 17, 2026

Feb 17, 2026

Richard Heyman plans Enliven (NASDAQ: ELVN) Rule 144 stock sale - Stock Titan

Feb 17, 2026

Feb 14, 2026

Will Enliven Therapeutics Inc. benefit from rising consumer demandJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - mfd.ru

Feb 14, 2026

Feb 14, 2026

What drives Enliven Therapeutics Inc.’s stock priceJuly 2025 Breakouts & Growth Focused Stock Reports - mfd.ru

Feb 14, 2026

Feb 14, 2026

Is Enliven Therapeutics Inc. stock attractive for income investorsProduct Launch & Daily Stock Trend Watchlist - mfd.ru

Feb 14, 2026

Feb 13, 2026

(ELVN) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Feb 13, 2026

Feb 11, 2026

History Review: Can Enliven Therapeutics Inc disrupt its industryWeekly Market Outlook & Smart Allocation Stock Tips - baoquankhu1.vn

Feb 11, 2026

Feb 11, 2026

Candriam S.C.A. Raises Stock Position in Enliven Therapeutics, Inc. $ELVN - MarketBeat

Feb 11, 2026

Feb 10, 2026

Enliven Therapeutics (NASDAQ:ELVN) Insider Sells $145,200.00 in Stock - MarketBeat

Feb 10, 2026

Feb 10, 2026

Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares By Investing.com - Investing.com UK

Feb 10, 2026

Feb 10, 2026

Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares - Investing.com

Feb 10, 2026

Feb 09, 2026

Aug Technicals: What drives Enliven Therapeutics Incs stock priceJuly 2025 Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn

Feb 09, 2026

Feb 06, 2026

Bear Alert: Will AdvanSix Inc stock hit new highs in YEARQuarterly Earnings Summary & Safe Entry Trade Reports - baoquankhu1.vn

Feb 06, 2026

Feb 06, 2026

Enliven Therapeutics (NASDAQ:ELVN) Sets New 1-Year HighWhat's Next? - MarketBeat

Feb 06, 2026

Feb 05, 2026

Aug Highlights: How sensitive is Enliven Therapeutics Inc to inflation2025 Performance Recap & Breakout Confirmation Trade Signals - baoquankhu1.vn

Feb 05, 2026

Feb 05, 2026

Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k - AOL.com

Feb 05, 2026

Feb 05, 2026

Heron Therapeutics (NASDAQ:HRTX) & Enliven Therapeutics (NASDAQ:ELVN) Head to Head Contrast - Defense World

Feb 05, 2026

Feb 04, 2026

Update Report: Can Enliven Therapeutics Inc disrupt its industryPortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn

Feb 04, 2026

Feb 03, 2026

Assessing Enliven Therapeutics (ELVN) Valuation After CSO Share Sale And Early Leukemia Trial Progress - Sahm

Feb 03, 2026

Feb 01, 2026

Enliven Therapeutics Executive Sells 20,000 Shares - Intellectia AI

Feb 01, 2026

Jan 31, 2026

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Pioneer with 61% Potential Upside - DirectorsTalk Interviews

Jan 31, 2026

Jan 28, 2026

Enliven Therapeutics CFO sells $22,524 in stock - MSN

Jan 28, 2026

Jan 27, 2026

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 27, 2026

Jan 27, 2026

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jan 27, 2026

Jan 27, 2026

Aug Sectors: What is DATSs valuation compared to sectorJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn

Jan 27, 2026

Jan 26, 2026

Market Outlook: Is Enliven Therapeutics Inc attractive for institutional investorsStop Loss & Low Risk High Win Rate Stock Picks - baoquankhu1.vn

Jan 26, 2026

Jan 24, 2026

Joseph Lyssikatos Sells 20,000 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - Defense World

Jan 24, 2026

Jan 24, 2026

Janux Therapeutics Inc (JANX) Gets a Buy from JonesTrading - The Globe and Mail

Jan 24, 2026

Jan 23, 2026

Enliven Therapeutics director Heyman sells $32,901 in stock By Investing.com - Investing.com South Africa

Jan 23, 2026

Jan 22, 2026

Day Trade: What hedge funds are buying TSLA2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn

Jan 22, 2026

Jan 22, 2026

Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock By Investing.com - Investing.com Canada

Jan 22, 2026

Jan 22, 2026

Enliven Therapeutics (NASDAQ:ELVN) Director Sells 1,230 Shares - MarketBeat

Jan 22, 2026